IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 133 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $29,444,000 | -30.8% | 930,000 | +1.4% | 6.08% | -12.0% |
Q4 2020 | $42,569,000 | -66.6% | 917,427 | -76.3% | 6.91% | -39.8% |
Q3 2020 | $127,618,000 | +24.8% | 3,876,600 | +4.1% | 11.48% | +40.5% |
Q2 2020 | $102,251,000 | +43.1% | 3,724,976 | +56.0% | 8.17% | +9.5% |
Q1 2020 | $71,473,000 | -48.5% | 2,387,606 | -52.4% | 7.47% | -38.2% |
Q4 2019 | $138,820,000 | +39.7% | 5,015,175 | -8.2% | 12.09% | +32.4% |
Q3 2019 | $99,387,000 | -99.9% | 5,460,803 | 0.0% | 9.13% | -38.6% |
Q2 2019 | $133,899,000,000 | +252802.1% | 5,460,803 | -1.9% | 14.86% | +183.7% |
Q1 2019 | $52,945,000 | +7.5% | 5,567,348 | 0.0% | 5.24% | -15.9% |
Q4 2018 | $49,271,000 | +25.3% | 5,567,348 | +59.2% | 6.23% | +1.6% |
Q3 2018 | $39,334,000 | -11.8% | 3,496,340 | +0.3% | 6.13% | -0.9% |
Q2 2018 | $44,618,000 | -99.9% | 3,485,745 | +5.0% | 6.18% | -25.8% |
Q1 2018 | $56,128,000,000 | +350700.0% | 3,321,173 | +66.1% | 8.34% | +205.3% |
Q4 2017 | $16,000,000 | +3.2% | 2,000,000 | 0.0% | 2.73% | -9.5% |
Q3 2017 | $15,500,000 | +1148.0% | 2,000,000 | +1083.3% | 3.02% | +1252.0% |
Q2 2017 | $1,242,000 | – | 169,014 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |